Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Viteava Pharmaceuticals

Viteava Pharmaceuticals
2013 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE (Announced)
4 INVESTORS
Description

Provider of anti-cancer compound isolated from green tea intended to improve the treatment and management of cancer and related conditions. The company's proprietary drug approach targets pathways that inhibit tumor cell proliferation, enabling the patient to enhance the quality of life.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Toronto, Ontario
  • Canada
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Viteava Pharmaceuticals’s full profile, request a free trial.

Viteava Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round Announced Startup
4. Accelerator/Incubator Completed Startup
3. Grant Completed Startup
2. Grant 01-Apr-2014 $27K Completed Startup
1. Accelerator/Incubator 28-Jan-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Viteava Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ontario Bioscience Innovation Organization Not-For-Profit Venture Capital 000 0000 000000 0
RIC Centre Accelerator/Incubator Minority 000 0000 000000 0
Canadian Institutes of Health Research Corporation 000 0000 000000 0
Canadian Technology Accelerator Accelerator/Incubator 000 0000 000000 0